140 related articles for article (PubMed ID: 12409828)
1. Analysis of duodenal drainage fluid after cholecystokinin (CCK) stimulation in healthy volunteers.
Conwell DL; Zuccaro G; Morrow JB; Van Lente F; O'Laughlin C; Vargo JJ; Dumot JA
Pancreas; 2002 Nov; 25(4):350-4. PubMed ID: 12409828
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin-stimulated peak lipase concentration in duodenal drainage fluid: a new pancreatic function test.
Conwell DL; Zuccaro G; Morrow JB; Van Lente F; Obuchowski N; Vargo JJ; Dumot JA; Trolli P; Shay SS
Am J Gastroenterol; 2002 Jun; 97(6):1392-7. PubMed ID: 12094856
[TBL] [Abstract][Full Text] [Related]
3. An endoscopic pancreatic function test with cholecystokinin-octapeptide for the diagnosis of chronic pancreatitis.
Conwell DL; Zuccaro G; Vargo JJ; Morrow JB; Obuchowski N; Dumot JA; Trolli PA; Burton A; O'laughlin C; Van Lente F
Clin Gastroenterol Hepatol; 2003 May; 1(3):189-94. PubMed ID: 15017490
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic pancreatic function test using combined secretin and cholecystokinin stimulation for the evaluation of chronic pancreatitis.
Law R; Lopez R; Costanzo A; Parsi MA; Stevens T
Gastrointest Endosc; 2012 Apr; 75(4):764-8. PubMed ID: 22281107
[TBL] [Abstract][Full Text] [Related]
5. Direct measurement of pancreatic enzymes after stimulation with secretin versus secretin plus cholecystokinin.
Del Rosario MA; Fitzgerald JF; Gupta SK; Croffie JM
J Pediatr Gastroenterol Nutr; 2000 Jul; 31(1):28-32. PubMed ID: 10896067
[TBL] [Abstract][Full Text] [Related]
6. Analysis of pancreatic elastase-1 concentrations in duodenal aspirates from healthy subjects and patients with chronic pancreatitis.
Stevens T; Conwell D; Zuccaro G; Van Lente F; Khandwala F; Hanaway P; Vargo JJ; Dumot JA
Dig Dis Sci; 2004 Sep; 49(9):1405-11. PubMed ID: 15481311
[TBL] [Abstract][Full Text] [Related]
7. The effect of moderate sedation on exocrine pancreas function in normal healthy subjects: a prospective, randomized, cross-over trial using the synthetic porcine secretin stimulated Endoscopic Pancreatic Function Test (ePFT).
Conwell DL; Zuccaro G; Purich E; Fein S; Vanlente F; Vargo J; Dumot J; O'laughlin C; Trolli P
Am J Gastroenterol; 2005 May; 100(5):1161-6. PubMed ID: 15842594
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzymes in human duodenal juice--a comparison of responses in secretin pancreozymin and Lundh Borgström tests.
Braganza JM; Herman K; Hine P; Kay G; Sandle GI
Gut; 1978 May; 19(5):358-66. PubMed ID: 658764
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pancreatic enzyme secretory capacity by a modified Lundh test.
Czakó L; Hajnal F; Németh J; Lonovics J
Int J Pancreatol; 2000 Feb; 27(1):13-9. PubMed ID: 10811019
[TBL] [Abstract][Full Text] [Related]
10. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
Lieb JG; Patel D; Karnik N; Toskes PP
Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653
[TBL] [Abstract][Full Text] [Related]
11. Electrolyte composition of endoscopically collected duodenal drainage fluid after synthetic porcine secretin stimulation in healthy subjects.
Stevens T; Conwell DL; Zuccaro G; Van Lente F; Khandwala F; Purich E; Vargo JJ; Fein S; Dumot JA; Trolli P; O'Laughlin C
Gastrointest Endosc; 2004 Sep; 60(3):351-5. PubMed ID: 15332022
[TBL] [Abstract][Full Text] [Related]
12. An enzyme immunoassay for the determination of lipase in human duodenal fluid.
Hafkenscheid JC; Hessels M; Kerstens PJ; Lamers CB
Pancreas; 1989; 4(1):90-4. PubMed ID: 2654930
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin release and biliopancreatic secretion in response to selective perfusion of the duodenal loop with aminoacids in man.
Colombel JF; Sutton A; Chayvialle JA; Modigliani R
Gut; 1988 Sep; 29(9):1158-66. PubMed ID: 3197988
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the marker technique for measurement of exocrine pancreatic secretion rate.
Rune SJ; Worning H
Scand J Gastroenterol; 1985 May; 20(4):525-9. PubMed ID: 4023620
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
[TBL] [Abstract][Full Text] [Related]
16. Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes.
Layer P; Jansen JB; Cherian L; Lamers CB; Goebell H
Gastroenterology; 1990 May; 98(5 Pt 1):1311-9. PubMed ID: 2323522
[TBL] [Abstract][Full Text] [Related]
17. Influence of exogenous application of pancreatic extracts on endogenous pancreatic enzyme secretion.
Mössner J; Stange JH; Ewald M; Kestel W; Fischbach W
Pancreas; 1991 Nov; 6(6):637-44. PubMed ID: 1723524
[TBL] [Abstract][Full Text] [Related]
18. A comparison of enzyme activities in duodenal aspirate following injection of secretin, caerulein, and cholecystokinin.
Vandermeers-Piret MC; Vandermeers A; Rathé J; Christophe J; Van der Hoeden R; Wettendorff P; Delcourt A
Digestion; 1974; 10(3):191-204. PubMed ID: 4850176
[No Abstract] [Full Text] [Related]
19. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
20. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
